What is the market doing?
What the tape says about RCUS
Arcus Biosciences, Inc. is +231% over the past year while the S&P 500 is +23%: 209 points ahead of the market.
+231%
1-year return · S&P 500 +23%
- vs 200-day average
- +30%
vs 200-day average · a clear uptrend
- RSI (14)
- 68
RSI (14) · neutral
- Below its 52-week high
- −2.6%
Below its 52-week high
Details›
- Last close2026-08-26
- $30.76
- 1 monthS&P 500 +3.7%
- +3.5%
- 1 yearS&P 500 +23%
- +231%
- 5 yearsS&P 500 +87%
- +2.3%
- vs 50-day average$27.40
- +12%
- 52-week high
- $31.57
- 52-week low
- $9.06
- Annualised volatility
- 62%
| Year | Return |
|---|---|
| 2026 (year to date) | +29% |
| 2025 | +60% |
| 2024 | −22% |
| 2023 | −7.6% |
| 2022 | −49% |
| 2021 | +56% |
| 2020 | +157% |
| 2019 | −6.2% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 2 of 8 | −6.2% |
| Feb | 8 | 5 of 8 | +13% |
| Mar | 8 | 3 of 8 | −7.7% |
| Apr | 9 | 4 of 9 | +8.0% |
| May | 9 | 4 of 9 | −2.5% |
| Jun | 9 | 4 of 9 | +0.48% |
| Jul | 9 | 4 of 9 | +0.15% |
| Aug | 9 | 6 of 9 | +7.0% |
| Sep | 8 | 4 of 8 | +2.4% |
| Oct | 8 | 3 of 8 | +1.4% |
| Nov | 8 | 7 of 8 | +18% |
| Dec | 8 | 2 of 8 | −2.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.